Id: acc3983
Group: 1sens
Protein: MLC
Gene Symbol: MLC1
Protein Id: Q15049
Protein Name: MLC1_HUMAN
PTM: phosphorylation
Site: Thr18
Site Sequence: ELAYDRMPTLERGRQDPASYA
Disease Category: Cardiovascular and circulatory system diseases
Disease: Barrier Dysfunction
Disease Subtype: vascular endothelial dysfunction
Disease Cellline: HPAEC
Disease Info:
Drug: 2-methoxyestradiol(2-ME)
Drug Info: 2-methoxyestradiol (2-ME) is a synthetic derivative of estradiol with potential anti-angiogenic and anti-tumor properties.
Effect: suppress
Effect Info: Tubacin pretreatment or Taxol can inhibit 2ME-induced phosphorylation of p38 and MLC and alleviate 2ME-induced vascular leakage.
Note:
Score: 5.0
Pubmed(PMID): 22074808
Sentence Index:
Sentence:

Sequence & Structure:

MTQEPFREELAYDRMPTLERGRQDPASYAPDAKPSDLQLSKRLPPCFSHKTWVFSVLMGSCLLVTSGFSLYLGNVFPAEMDYLRCAAGSCIPSAIVSFTVSRRNANVIPNFQILFVSTFAVTTTCLIWFGCKLVLNPSAININFNLILLLLLELLMAATVIIAARSSEEDCKKKKGSMSDSANILDEVPFPARVLKSYSVVEVIAGISAVLGGIIALNVDDSVSGPHLSVTFFWILVACFPSAIASHVAAECPSKCLVEVLIAISSLTSPLLFTASGYLSFSIMRIVEMFKDYPPAIKPSYDVLLLLLLLVLLLQAGLNTGTAIQCVRFKVSARLQGASWDTQNGPQERLAGEVARSPLKEFDKEKAWRAVVVQMAQ

No data.

Known Drugs:

source: Multi-Sources

(see table)

No data.

Protein Tractability:

source: Open Targets
Small molecule
Antibody
PROTAC
Other modalities
Approved Drug
Advanced Clinical
Phase 1 Clinical
Structure with Ligand
High-Quality Ligand
High-Quality Pocket
Med-Quality Pocket
Druggable Family
Approved Drug
Advanced Clinical
Phase 1 Clinical
UniProt loc high conf
GO CC high conf
UniProt loc med conf
UniProt SigP or TMHMM
GO CC med conf
Human Protein Atlas loc
Approved Drug
Advanced Clinical
Phase 1 Clinical
Literature
UniProt Ubiquitination
Database Ubiquitination
Half-life Data
Small Molecule Binder
Approved Drug
Advanced Clinical
Phase 1 Clinical

PTM Intensity:

source: CPTAC

No data.

PTM-Disease Association:

source: PTMD

No data.

PTM-Drug Perturbation Response:

source: DecryptM

No data.

Function score:

source: funscoR

No data.

Cross Links: